Source: HIV medicine [HIV Med] 2005 Sep; Vol. 6 (5), pp. 334-40.Publisher: Wiley Country of Publication: England NLM ID: 100897392 Publication Model: Print Cited Medium: Print ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Comparison of gastrointestinal tolerability and patient preference for treatment with the 625 mg and 250 mg nelfinavir tablet formulations.

Authors : Johnson M; Royal Free Hospital, London, UK. ; Nieto-Cisneros L

Subjects: HIV-1* ; Patient Satisfaction*; Diarrhea/Diarrhea/Diarrhea/*chemically induced

Source: HIV medicine [HIV Med] 2005 Mar; Vol. 6 (2), pp. 107-13.Publisher: Wiley Country of Publication: England NLM ID: 100897392 Publication Model: Print Cited Medium: Print ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

The anti‐HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV‐2 spike (S) glycoprotein warranting further evaluation as an antiviral against COVID‐19 infections

Authors : Farhana Musarrat; Vladimir N. Chouljenko; Konstantin G. Kousoulas

Subjects: viruses; coronavirus; medicine.disease_cause

Source: Journal of Medical Virology

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Characterization of nelfinavir binding to plasma proteins and the lack of drug displacement interactions.

Authors : Motoya T; Department of Clinical Pharmacy, University of California at San Francisco, San Francisco, CA 94143-0622, USA.; Thevanayagam LN

Subjects: Blood Proteins/Blood Proteins/Blood Proteins/*metabolism ; HIV Protease Inhibitors/HIV Protease Inhibitors/HIV Protease Inhibitors/*blood ; Nelfinavir/Nelfinavir/Nelfinavir/*blood

Source: HIV medicine [HIV Med] 2006 Mar; Vol. 7 (2), pp. 122-8.Publisher: Wiley Country of Publication: England NLM ID: 100897392 Publication Model: Print Cited Medium: Print ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Determination of indinavir and nelfinavir trough plasma concentration efficacy thresholds according to virological response in HIV-infected patients.

Authors : Duval X; Infectious and Tropical Diseases, Bichat-Claude Bernard Hospital, Paris, France. ; Peytavin G

Subjects: Drug Monitoring* ; HIV-1*; HIV Infections/HIV Infections/HIV Infections/*drug therapy

Source: HIV medicine [HIV Med] 2004 Jul; Vol. 5 (4), pp. 307-13.Publisher: Wiley Country of Publication: England NLM ID: 100897392 Publication Model: Print Cited Medium: Print ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

The use of calcium carbonate in nelfinavir-associated diarrhoea in HIV-1-infected patients.

Authors : Jensen-Fangel S; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark. ; Justesen US

Subjects: Calcium Carbonate/Calcium Carbonate/Calcium Carbonate/*therapeutic use ; Diarrhea/Diarrhea/Diarrhea/*drug therapy ; HIV Infections/HIV Infections/HIV Infections/*drug therapy

Source: HIV medicine [HIV Med] 2003 Jan; Vol. 4 (1), pp. 48-52.Publisher: Wiley Country of Publication: England NLM ID: 100897392 Publication Model: Print Cited Medium: Print ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Pharmacokinetics of Increased Nelfinavir Plasma Concentrations in Women During Pregnancy and Postpartum

Authors : Lynne M. Mofenson; Regis Kreitchmann; Impaact Study Team

Subjects: Adult; medicine.medical_specialty; Anti-HIV Agents

Source: The Journal of Clinical Pharmacology. 59:386-393

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Improving the efficacy of proteasome inhibitors in the treatment of renal cell carcinoma by combination with the human immunodeficiency virus (HIV)-protease inhibitors lopinavir or nelfinavir

Authors : Ondrej Slaby; Lenka Besse; Juergen Bader

Subjects: 0301 basic medicine; Urology; Antineoplastic Agents

Source: BJU International. 121:600-609

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Electrochemical Oxidation of the Antiretroviral Drug Nelfinavir on Modified Screen-printed Electrodes

Authors : Olga Domínguez-Renedo; Laura Asturias-Arribas; M. Asunción Alonso-Lomillo

Subjects: Analyte; Network Functions Virtualization; Chromatography

Source: Electroanalysis. 28:2081-2086

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Impact of CYP2C19 polymorphism on the pharmacokinetics of nelfinavir in patients with pancreatic cancer

Authors : Chalet Tan; Ruby E. Evande; Goutam Mondal

Subjects: Pharmacology; business.industry; Metabolite

Source: British Journal of Clinical Pharmacology. 80:267-275

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

The long-term pharmacokinetics and safety of adding low-dose ritonavir to a nelfinavir 1,250 mg twice-daily regimen in HIV-infected patients.

Comparison of gastrointestinal tolerability and patient preference for treatment with the 625 mg and 250 mg nelfinavir tablet formulations.

The anti‐HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV‐2 spike (S) glycoprotein warranting further evaluation as an antiviral against COVID‐19 infections

Characterization of nelfinavir binding to plasma proteins and the lack of drug displacement interactions.

Determination of indinavir and nelfinavir trough plasma concentration efficacy thresholds according to virological response in HIV-infected patients.

The use of calcium carbonate in nelfinavir-associated diarrhoea in HIV-1-infected patients.

Pharmacokinetics of Increased Nelfinavir Plasma Concentrations in Women During Pregnancy and Postpartum

Improving the efficacy of proteasome inhibitors in the treatment of renal cell carcinoma by combination with the human immunodeficiency virus (HIV)-protease inhibitors lopinavir or nelfinavir

Electrochemical Oxidation of the Antiretroviral Drug Nelfinavir on Modified Screen-printed Electrodes

Impact of CYP2C19 polymorphism on the pharmacokinetics of nelfinavir in patients with pancreatic cancer

اتصل بنا

اتبع